Genocea Biosciences is Drug Discovery in United States that focus on Genocea Biosciences Inc business. Founded in 2006. They cover business area such as Genocea Biosciences Inc, novel vaccine, immunotherapy, disease, significant unmet need, its product candidate, genital herpe, pre-clinical immuno-oncology program, personalized cancer vaccine, its AnTigen Lead Acquisition System, its business, develop and commercialize vaccine.
2006
( 18 years old in 2024 )
Genocea Biosciences Inc
-
100 Acorn Park Drive
Cambridge, MA 02140
United States
Private
Genocea Biosciences Incnovel vaccineimmunotherapydiseasesignificant unmet needits product candidategenital herpepre-clinical immuno-oncology programpersonalized cancer vaccineits AnTigen Lead Acquisition Systemits businessdevelop and commercialize vaccine
* We use standard office opening hours in near Genocea Biosciences's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Genocea Biosciences is Drug Discovery business from United States that founded in 2006 (18 years old in 2024), Genocea Biosciences business is focusing on Genocea Biosciences Inc.
Genocea Biosciences headquarter office and corporate office address is located in 100 Acorn Park Drive Cambridge, MA 02140 United States.
Genocea Biosciences was founded in United States.
In 2024, Genocea Biosciences is currently focus on Genocea Biosciences Inc sector.
Above is snippet of Google Trends for "Genocea Biosciences Inc" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Genocea Biosciences, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
